NCT00286845View on ClinicalTrials.gov

Use of the MiCK Assay for Apoptosis in AML

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

December 31, 2009

Conditions
Leukemia, Myelocytic, Acute
Interventions
DRUG

Standard Chemotherapy

physician determined

Trial Locations (1)

37212

Vanderbilt University Medical Center and DiaTech Oncology, Nashville

Sponsors
All Listed Sponsors
collaborator

DiaTech Oncology and Vanderbilt University

OTHER

lead

Pierian Biosciences

INDUSTRY